B9KFM1 AF NFT

Polyribonucleotide nucleotidyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiaw7khgzaob65iblkkwpsovc2zgykkjjgeyaiggk4vt4eymlu2zb4/metadata.json
IPFS of structure file: 
bafybeifb4h5ptrpfeeb2vx6fbgduvjs6l7vurzxxb3my52sxmgig6au66u/AF-B9KFM1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xd1A2963012bEcbC7A8f505464439Ab678C48936f
First NFT owner address (bech32): 
genesis16x3fvvqjhm9u0284q4rygwdtv7xy3ym0jw3rdp
Current NFT ID #304107 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
304107
Accession (UniProt):
B9KFM1
Name::
Polyribonucleotide nucleotidyltransferase
Experimental Method:
Predicted structure
Sequence source:
Campylobacter lari (strain RM2100 / D67 / ATCC BAA-1060)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B9KFM1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B9KFM1|PNP_CAMLR Polyribonucleotide nucleotidyltransferase OS=Campylobacter lari (strain RM2100 / D67 / ATCC BAA-1060) OX=306263 GN=pnp PE=3 SV=1 MRHKININNHIEIFDTDKVAKQAAGAVLMQEKNAVVLATVAREEKMVEEDFLPLTVQYIEKAYAAGKIPGGYVKRETKPGDSETLSARIIDRSLRPLFPKGYAYPTQIVVMVLSADPEVDLQVMSLNAASVALYLSDIPIKAPVCGVRIGRINNEFVLNPSNSELKNSTLDLYVAGVKDELLMIEMRALSNKKDNQHCMNELSEDDTLKALDFASSAILRGSNEYEKAFAAYRKNSKLEFKIESDNIQIIDYIKNTYITKLKIAINQMAKSERASEILQIAKEIESESMAIENEWKFEDIEKALHVCKRELVRNQIINENKRADGRGLKDVRKIDIETNILPSAHGSCLFTRGQTQALVVATLGNDNDAQMSDMLTEKNPICEKFMVNYNFPGFSVGEASPIKAPGRRELGHGNLAKRALYPSVDADYIHTIRLVSEILESNGSSSMATVCGGALALRAAGVKSEKLVAGVAMGLVFEEEKYAILTDIMGLEDHDGDMDFKVAGSHDGITALQMDIKLGGIEQKVLQEALYQAKEARGYILNLMQEACEKIIVNEAILPKVEIFNVDPNKIPDIIGQGGKTIKDIIEKFEVNIDLDRDKGEVKIAGIDHNLISQSKEYILNLLHSKGSNKRRDKKEMPKFDIGEEFLGRVQKVVEFGVFVELKEGVDGLLHNSKIKEKLEVGHEIKVKVAEIKNGKVSLDLA